Extraskeletal Myxoid Chondrosarcoma Mimicking Myoepithelial Tumor
Case Reports in Pathology · 2026-01 · 2026 (1)
DOI: 10.1155/crip/2779791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Pathology, online erschienen am 03.05.2026. Verfasst von Bowen Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, hokudai.ac.jp. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma defined by its characteristic multinodular myxoid architecture and distinctive clinicopathological features. Although EMC typically exhibits a multinodular myxoid architecture, its histologic variability and frequent immunophenotypic overlap with other myxoid tumors can make diagnosis challenging. We report a case of EMC arising around the left knee of a 73‐year‐old male patient. Histologically, the tumor exhibited abundant myxoid stroma with lace‐like and haphazard cellular arrangements and focal epithelioid morphology. Immunohistochemically, the lesion showed diffuse positivity for several myoepithelial markers, including epithelial membrane antigen, α –smooth muscle actin, HHF35, calponin, and p63. However, the absence of cytokeratin and SOX10 expression raised diagnostic uncertainty despite the myoepithelial‐like immunoprofile. Because immunohistochemistry remained inconclusive, targeted RNA sequencing was performed on formalin‐fixed, paraffin‐embedded tissue. A TAF15 :: NR4A3 fusion transcript was identified, leading to revision of the initial diagnosis to EMC. At 3‐year follow‐up, the patient remains free of recurrence or metastasis. This case demonstrates the potential for EMC to mimic myoepithelial tumors and supports the use of molecular analysis when histologic or immunohistochemical findings are insufficient for diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, hokudai.ac.jp.
- Center for Development of Advanced Diagnostics, Hokkaido University Hospital, Sapporo, Japan, hokudai.ac.jp.
- Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan, hokudai.ac.jp.
- Laboratory of Genomic Pathology, Osaka International Cancer Institute, Osaka, Japan, pref.osaka.jp.
- DNA Chip Research Inc, Kawasaki-shi, Kanagawa, Japan.
- Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan, hokudai.ac.jp.
ORCID-Profile: Masatake Matsuoka, Harumi Nakamura, Shinya Tanaka
Zitieren
APA
Jiang, B., Matsuoka, M., Hatanaka, K. C., Nakazato, S., Nakamura, H., Nakamura, S., Shimizu, H., Onodera, T., Tanaka, S., Hatanaka, Y., & Iwasaki, N. (2026). Extraskeletal Myxoid Chondrosarcoma Mimicking Myoepithelial Tumor. Case Reports in Pathology, 2026(1). https://doi.org/10.1155/crip/2779791
Vancouver
Jiang B, Matsuoka M, Hatanaka KC, Nakazato S, Nakamura H, Nakamura S, et al. Extraskeletal Myxoid Chondrosarcoma Mimicking Myoepithelial Tumor. Case Reports in Pathology. 2026;2026(1). doi:10.1155/crip/2779791
BibTeX
@article{Jiang2026,
author = {Jiang, Bowen and Matsuoka, Masatake and Hatanaka, Kanako C and Nakazato, Shinichi and Nakamura, Harumi and Nakamura, Seiji and Shimizu, Hirokazu and Onodera, Tomohiro and Tanaka, Shinya and Hatanaka, Yutaka and Iwasaki, Norimasa},
title = {Extraskeletal Myxoid Chondrosarcoma Mimicking Myoepithelial Tumor},
journal = {Case Reports in Pathology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crip/2779791}
}
EUVIMED